At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 14 enrolled
Drug / intervention
Zilucoplandrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label, Single Center, Randomized, 2-Way Crossover, Single-Dose, Bioequivalence Study of Zilucoplan Injected Subcutaneously Either by a Prefilled Syringe or an Auto-Injector in Healthy Adult Participants
In Brief
A Phase 1 clinical trial evaluating Zilucoplan for Healthy Volunteers. Completed, enrolled 14 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the bioequivalence pharmacokinetics, safety, tolerability and device deficiencies of zilucoplan (ZLP) in healthy adult participants
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesNetherlands
Collaborators--
Timeline
Phase 1CompletedFinished
20252026
First PostedJul 2024
Enrollment StartAug 2024
Primary CompletionNov 2024
TodayJul 2026
First PostedJul 19, 2024
Enrollment StartAug 5, 2024
Primary CompletionNov 26, 2024
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 2.0 years ago
Interventions
Zilucoplandrug
Participants will receive a single sc injection of zilucoplan in the pre-specified sequence.